| Phone | 312-466-3750 |
| Employees |
Lurie Investment Fund is the venture capital arm of the Ann and Robert H. Lurie Foundation specializing in venture capital and private equity investments. The firm seeks to invest in biomedical community, mainly in medical devices, therapeutics, diagnostics and services, nanotechnology, and MEMS technology.
| Company | Date | Round | Size | Participants |
| CytoPherx | 1/12 | Venture Round | $34M | 7 |
| NanoInk | 10/10 | Series E | $65M | 1 |
| Discera | 1/10 | Series D | $11M | 3 |
| Viamet Pharmaceuticals | 7/09 | Series B | $18M | 6 |
| Cernium | 12/07 | Venture Round | $10M | 1 |
| RenaMed Biologics | 9/06 | Venture Round | $40M | 9 |
| Cernium | 11/05 | Series D | $7.5M | 1 |